Sotera Health Company (NASDAQ:SHC) Receives $17.80 Consensus Target Price from Brokerages

by · The Cerbat Gem

Shares of Sotera Health Company (NASDAQ:SHC – Get Free Report) have been given a consensus rating of “Moderate Buy” by the six ratings firms that are covering the stock, Marketbeat reports. Three analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $17.80.

A number of research firms recently issued reports on SHC. Wall Street Zen raised Sotera Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 16th. Barclays boosted their target price on shares of Sotera Health from $19.00 to $20.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. Weiss Ratings reissued a “hold (c-)” rating on shares of Sotera Health in a research note on Tuesday. Piper Sandler raised their price objective on Sotera Health from $15.00 to $17.00 and gave the stock a “neutral” rating in a research note on Wednesday, November 5th. Finally, BMO Capital Markets started coverage on Sotera Health in a research report on Thursday, November 13th. They set an “outperform” rating and a $19.00 target price on the stock.

Read Our Latest Stock Analysis on Sotera Health

Insider Buying and Selling at Sotera Health

In other news, Director Pincus & Co. Warburg sold 12,000,000 shares of Sotera Health stock in a transaction on Friday, September 5th. The stock was sold at an average price of $15.11, for a total transaction of $181,320,000.00. Following the transaction, the director owned 61,822,952 shares in the company, valued at approximately $934,144,804.72. The trade was a 16.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Gtcr Investment Xi Llc sold 12,000,000 shares of the firm’s stock in a transaction dated Monday, November 10th. The stock was sold at an average price of $15.65, for a total value of $187,800,000.00. Following the sale, the director owned 29,215,301 shares of the company’s stock, valued at $457,219,460.65. The trade was a 29.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 32,000,000 shares of company stock worth $490,000,000. Company insiders own 47.55% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the business. TPG GP A LLC bought a new stake in Sotera Health in the first quarter worth $79,126,000. Sculptor Capital LP lifted its position in shares of Sotera Health by 80.8% in the first quarter. Sculptor Capital LP now owns 9,037,511 shares of the company’s stock worth $105,377,000 after buying an additional 4,037,511 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of Sotera Health by 10.5% during the 3rd quarter. Vanguard Group Inc. now owns 16,471,792 shares of the company’s stock worth $259,101,000 after acquiring an additional 1,561,282 shares in the last quarter. Voss Capital LP increased its holdings in shares of Sotera Health by 146.7% during the 3rd quarter. Voss Capital LP now owns 1,850,000 shares of the company’s stock valued at $29,100,000 after acquiring an additional 1,100,000 shares during the last quarter. Finally, Norges Bank bought a new position in shares of Sotera Health in the 2nd quarter valued at approximately $9,607,000. Institutional investors own 91.03% of the company’s stock.

Sotera Health Price Performance

NASDAQ SHC opened at $16.84 on Friday. Sotera Health has a 52 week low of $9.53 and a 52 week high of $17.78. The company has a current ratio of 2.38, a quick ratio of 2.18 and a debt-to-equity ratio of 4.04. The stock has a market cap of $4.78 billion, a price-to-earnings ratio of 88.64 and a beta of 1.81. The company has a 50-day moving average price of $16.27 and a two-hundred day moving average price of $14.30.

Sotera Health (NASDAQ:SHC – Get Free Report) last announced its earnings results on Tuesday, November 4th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.04. Sotera Health had a return on equity of 43.69% and a net margin of 4.82%.The firm had revenue of $311.31 million for the quarter, compared to the consensus estimate of $303.63 million. Sotera Health has set its FY 2025 guidance at 0.810-0.860 EPS. Analysts forecast that Sotera Health will post 0.61 EPS for the current year.

Sotera Health Company Profile

(Get Free Report)

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.

See Also